CAMP – camp4 therapeutics corporation (US:NASDAQ)

News

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMP4 Therapeutics (CAMP) is now covered by Rodman & Renshaw. They set a "buy" rating on the stock.
CAMP4 Appoints Michael MacLean to its Board of Directors
CAMP4 to Participate in Upcoming Investor Conferences
CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com